Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eliava Bio Preparations is a specialized biotechnology company based in Tbilisi, Georgia, focused on the development and commercial production of bacteriophage-based therapeutic products. As the commercial manufacturing arm of the historic George Eliava Institute of Bacteriophages, Microbiology and Virology, the company utilizes over a century of institutional knowledge to combat antibiotic-resistant bacterial infections. Their product portfolio includes several standardized phage cocktails, such as Pyo-bacteriophage and Intesti-bacteriophage, which are designed to target specific groups of pathogenic bacteria. These products are used to treat a variety of conditions ranging from gastrointestinal disorders to chronic wound infections and respiratory ailments. Eliava Bio Preparations serves a global market, providing essential alternatives to traditional antibiotics in the face of rising antimicrobial resistance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eliava Bio Preparations.